Acuitas Investments’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $218K | Hold |
491,092
| – | – | 0.17% | 49 |
|
|
2025
Q1 | $278K | Hold |
491,092
| – | – | 0.24% | 54 |
|
|
2024
Q4 | $1.04M | Hold |
491,092
| – | – | 0.85% | 43 |
|
|
2024
Q3 | $1.32M | Buy |
491,092
+83,749
| +21% | +$225K | 0.59% | 67 |
|
|
2024
Q2 | $1.16M | Buy |
407,343
+80,827
| +25% | +$230K | 0.62% | 63 |
|
|
2024
Q1 | $1.38M | Hold |
326,516
| – | – | 0.7% | 55 |
|
|
2023
Q4 | $1.75M | Buy |
326,516
+84,735
| +35% | +$453K | 0.91% | 47 |
|
|
2023
Q3 | $1.04M | Buy |
241,781
+61,481
| +34% | +$264K | 0.61% | 59 |
|
|
2023
Q2 | $990K | Buy |
+180,300
| New | +$990K | 0.58% | 62 |
|
|
2022
Q1 | – | Sell |
-432,445
| Closed | -$3.05M | – | 46 |
|
|
2021
Q4 | $3.05M | Buy |
432,445
+56,609
| +15% | +$399K | 1.3% | 38 |
|
|
2021
Q3 | $2.62M | Buy |
375,836
+49,345
| +15% | +$344K | 1.15% | 44 |
|
|
2021
Q2 | $2.72M | Buy |
326,491
+126,491
| +63% | +$1.05M | 1.36% | 36 |
|
|
2021
Q1 | $1.09M | Buy |
+200,000
| New | +$1.09M | 0.63% | 65 |
|